279 related articles for article (PubMed ID: 9263537)
1. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.
Hasebe T; Tsuda H; Tsubono Y; Imoto S; Mukai K
Jpn J Cancer Res; 1997 Jun; 88(6):590-9. PubMed ID: 9263537
[TBL] [Abstract][Full Text] [Related]
2. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients.
Hasebe T; Tsuda H; Hirohashi S; Shimosato Y; Tsubono Y; Yamamoto H; Mukai K
Breast Cancer Res Treat; 1998 Jun; 49(3):195-208. PubMed ID: 9776503
[TBL] [Abstract][Full Text] [Related]
3. A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.
Hasebe T; Imoto S; Sasaki S; Mukai K
Jpn J Cancer Res; 1998 Dec; 89(12):1358-73. PubMed ID: 10081498
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
[TBL] [Abstract][Full Text] [Related]
5. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness.
Hasebe T; Tsuda H; Hirohashi S; Shimosato Y; Iwai M; Imoto S; Mukai K
Jpn J Cancer Res; 1996 Apr; 87(4):385-94. PubMed ID: 8641970
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study.
Hasebe T; Sasaki S; Imoto S; Mukai K; Yokose T; Ochiai A
Mod Pathol; 2002 May; 15(5):502-16. PubMed ID: 12011255
[TBL] [Abstract][Full Text] [Related]
7. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Ochiai A
Mod Pathol; 2001 Apr; 14(4):325-37. PubMed ID: 11301349
[TBL] [Abstract][Full Text] [Related]
8. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
[TBL] [Abstract][Full Text] [Related]
9. Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast.
Koyama T; Hasebe T; Tsuda H; Hirohashi S; Sasaki S; Fukutomi T; Imoto S; Umeda T; Mukai K
Jpn J Cancer Res; 1999 Mar; 90(3):294-300. PubMed ID: 10359044
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients.
Levesque MA; Katsaros D; Yu H; Giai M; Genta F; Roagna R; Ponzone R; Massobrio M; Sismondi P; Diamandis EP
Int J Cancer; 1998 Apr; 79(2):147-52. PubMed ID: 9583729
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study.
Hasebe T; Imoto S; Yokose T; Ishii G; Iwasaki M; Wada N
Hum Pathol; 2008 May; 39(5):681-93. PubMed ID: 18329692
[TBL] [Abstract][Full Text] [Related]
13. Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer.
Iwaya K; Tsuda H; Fukutomi T; Tsugane S; Suzuki M; Hirohashi S
Jpn J Clin Oncol; 1997 Feb; 27(1):6-12. PubMed ID: 9070333
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
15. Primary tumour-vessel tumour-nodal tumour classification for patients with invasive ductal carcinoma of the breast.
Hasebe T; Sasaki S; Imoto S; Wada N; Ishii G; Ochiai A
Br J Cancer; 2005 Mar; 92(5):847-56. PubMed ID: 15756255
[TBL] [Abstract][Full Text] [Related]
16. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
17. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
19. Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.
Mujtaba SS; Ni YB; Tsang JY; Chan SK; Yamaguchi R; Tanaka M; Tan PH; Tse GM
Ann Surg Oncol; 2013 Sep; 20(9):2842-9. PubMed ID: 23539156
[TBL] [Abstract][Full Text] [Related]
20. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
